Wounds UK E-Newsletter for March 2010
Visit the Wounds UK Bookstore  
Wounds UK
UK TIME Advisory Board
Wound Care E-Newsletter
 

Click here for the Wounds UK Home Page

March 2010


Forthcoming Events    

read more

Wounds International Volume 1 Issue 2        

read more
Editorial

The burden of lower limb disease is one which cannot be ignored by any Government and yet there does not seem to be an allocation of resources which matches patient need. I have used the term lower limb disease here, but this is at best an oversimplification. Lower limb disease includes arterial disease, venous disease, diabetic foot disease and lymphoedema, to name but a few.

As our patient group ages, there is an increasing risk of developing lower limb problems. As the patients’ vascular networks lose efficiency, low level tissue ischaemia may occur, which may eventually become peripheral arterial occlusive disease or in some cases the impact may be sub clinical. The signs and symptoms of which will vary from patient to patient, however, the pain and effect on the patients’ mobility are severe, and will impact on all aspects of the patients’ lifestyle. It is likely that the patient will require surgery, which may or may not be successful and for some, amputation will be inevitable.

Venous disease also affects a significant number of patients and for those who go on to develop leg ulceration it is likely that they will be in the healthcare system for a lengthy period of time. Long term venous changes which result in the swelling of the limb as a result of venous hypertension, may then cause secondary lymphatic disease, leading to chronic swelling in the lower limb. Patients with complex leg ulcers and lymphoevenous disease, often present with a distressing array of symptoms which may include loss of mobility, varicose eczema, heavy levels of exudate and chronic recurring infections.

In April this year Wounds UK will be hosting a conference which highlights the problems of lymphoedema and skin changes in lower limb disease. The programme involves speakers from around the globe as well as a host of UK experts.

For more information go to www.wounds-uk.com or www.lymphoedema-uk.com

Click here to download the programme

John Timmons
Editor

Useful References     

Latest references

read more


Forthcoming Events

Tissue Viability Society 2010 Annual Conference

Tuesday and Wednesday 14th April 2010, Telford

Wound Diagnostic Masterclass

21st April 2010, Ascot Racecourse

A one-day Wounds International masterclass on the emerging specialty of assessment and diagnosis in wounds.

Wounds International Conference 2011, Cape Town, South Africa

1st February to 3rd February 2011

This conference will bring together healthcare professionals from around the world to share experiences and best practices across the international wound care community.

Prove it

14th & 15th September 2010, University of Essex, Colchester

A 2 day independent wound care conference which includes:
- Examining the evidence in wound care and how it informs practice, with presentations by tissue viability experts from across the UK.
- A debate on the types of evidence available and questioning are randomised controlled trials the real gold standard?

For more information download the flyer

return to top

Keep reading for:
Wounds International Issue two now available
KCI announces Drug Tariff for disposables
Useful References

Download this newsletter in PDF format

Wounds International Issue two now available:

February 2010:

Wounds International Volume 1 Issue 2
The launch of Wounds International has been well received by clinicians and industry, with visitors from over 90 countries viewing the first issue, confirming that there is indeed a genuine need for a 'journal' providing international content that is short, interesting, reliable and relevant. The second issue of the Wounds International journal is now available online.

To view this issue click here

 

Focus on Diabetic Foot Ulcers

The February issue focuses on diabetic foot ulcers and looks at key developments in practice around the world.

  • David Armstrong's team in the US look at the latest developments in therapy including the use of biguanides, NPWT, and bioengineered alternative tissues using a wound healing timeline.
  • Jan Apelqvist from Sweden calls for a new classification system for neuroishaemic ulcers.
  • Alberto Piaggesi states that a new super-oxidised solution should become the first option when local antiseptics are required
  • The Shankhdhar family assert that in developing countries like India, there is a need for new treatment approaches to be simple, economical and effective.
  • Zulfiqarali Abbas describes a step-by-step programme to help reduce amputation rates in Tanzania.

Diabetic foot ulcer digest provides a round up of all the important recent research, shared by our sister publications Diabetic Digest and Diabetic Foot Journal

To view this issue click here

 

Exudate Management Made Easy

The second of the innovative 'Made Easy' series looks at: What is exudate? How do I know when exudate is a problem? How do I choose an appropriate dressing?

Marco Romanelli, Dot Weir and Kath Vowden urge clinicians to take time to understand this important topic in order to improve patients' quality of life, promote healing and avoid unnecessary healthcare costs.

Exudate management made easy has been supported by Convatec.

To view this article click here

 

Other features in this issue

  • Keryln Carville reviews key innovations in pressure ulcers in Australia, which have led to reduced prevalence rates and a new online education programme.
  • Geoff Sussman describes the chemistry of modern foam dressings and their use in a variety of wound types, Jacqui Fletcher stresses that foam dressings are 'simple and easy to use' and 'in a world where wound care is increasingly being provided by unqualified practitioners', foam is a good choice - 'you simply peel and stick'.
  • Case reports - Mike Edmonds congratulates Jane Jeavons on the sterling job her and her colleagues have done in managing a patient with a plantar ulcer associated with Charcot foot and suggests Facebook and telemedicine may be helpful when managing patients in remote areas. Sarah Bagazi emphasizes the need for multidisciplinary care in managing a complex postoperative case and discusses the impact of ulceration on psychological and socail wellbeing.

To view this issue, click here

 

The chronic wound debate

Michael Stacey and Gerald Lazarus take up the chronic wound debate raised by Ron Legerstee in the launch issue in which he questions the use of the descriptor 'chronic'.

The concern is that using a term such as 'chronic' will lead to professionals having a 'myopic and negative approach to wounds'. According to Mike Stacey, we still need to define and agree what 'chronic' means in relation to a wound. Gerald Lazarus states that clinicians need to investigate the specific factors that delay healing. 'Care for the 'wound' is critical but all too often we forget that the general health status of the patient affects the healing rate.'

To view this article, click here

return to top

Keep reading for:
KCI announces Drug Tariff for disposables
Useful References

Download this newsletter in PDF format

KCI announce drug tariff for disposables

KCI have announced that all of its V.A.C.® Therapy System disposables have been granted reimbursement status and are now listed on the UK Drug Tariff. As of March 1, 2010, V.A.C.® Gel Strip, SensaT.R.A.C™ Pad, V.A.C.® Drape and Y-Connector will be available on prescription with the remaining four products in the portfolio, V.A.C.® GranuFoam™ Bridge Dressing Kit, V.A.C.® Simplace™ Dressing kits (small & medium), V.A.C.® WhiteFoam (small & large) and V.A.C.® WhiteFoam Dressing kit (small & large) available as of April 1, 2010.

These products join KCI's ActiV.A.C.® canister, V.A.C. Freedom ® canister and V.A.C.® GranuFoam&trafe; dressing kits, already listed on the UK Drug Tariff.

The listing signifies an important development in the provision of access to the latest Negative Pressure Wound Therapy (NPWT) helping to facilitate patient transition to the non-acute care setting, while ensuring effective wound management within the home.

Paul Blaket, General Manager of KCI Medical, Ltd. commented: "We are delighted our products have been granted reimbursement status. The listing is a significant milestone for KCI within the UK reimbursement business as we can now extend our reach into the post-acute care market, where we know that 80% of wounds reside. We anticipate the listing will have a positive impact on patient care in the UK as broader access to KCI therapies will increase quality of life as more patients are able to be treated at home.

For more information visit www.kci1.com

return to top

Keep reading for:
Useful References

Download this newsletter in PDF format

References

Daly, M.C.; Faul, J.; Steinberg, J.S. (2010) Hyperbaric Oxygen Therapy as an Adjunctive Treatment for Diabetic Foot Wounds: A Comprehensive Review With Case Studies. WOUNDS VOL 22; NUMB 1; pp. 1-11

Gulcelik, M.A.; Dincer, H.; Sahin, D.; Demir, O.F.; Yenidogan, E.; Alagol, H. Glucan Improves Impaired Wound Healing in Diabetic Rats. WOUNDS VOL 22; NUMB 1; pp. 12-16

Solway, D.R.; Consalter, M.; Levinson, D.J. (2010) Microbial Cellulose Wound Dressing in the Treatment of Skin Tears in the Frail Elderly. WOUNDS VOL 22; NUMB 1; pp. 17-19

Galhardo, V.A.C.; Magalhaes, M.G.; Blanes, L.; Juliano, Y.; Ferreira, L.M. Health-related Quality of Life and Depression in Older Patients With Pressure Ulcers. WOUNDS VOL 22; NUMB 1; pp. 20-25

 

return to top

Download this newsletter in PDF format

Click here for the Wounds UK Home Page

March 2010

©Wounds UK Ltd

Website design: Mole Productions